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Abstract: Background: Obstructive sleep apnoea (OSA) results in sympathetic overdrive. Increased noc-
turnal heart rate variability (HRV) is a surrogate marker of autonomic disturbance. The aim was to study
the association of the apnoea-hypopnea index (AHI), nocturnal hypoxaemia, and sleep fragmentation with
nocturnal HRV to address the pathophysiological mechanisms underlying autonomic disturbance in OSA.
Methods: Participants of the Sleep Hearth Health Study with available data on nocturnal HRV and an
AHI ฀10/h have been included in this cross-sectional analysis. The main outcome of interest was the as-
sociation of sleep fragmentation, nocturnal hypoxaemia, and the AHI with nocturnal HRV. Multivariate
regression modelling with the mean of the standard deviations of normal-sinus-to-normal-sinus-interbeat
intervals in all 5-minute segments (SDNNIDX) and with low to high frequency power-ratio (LF/HF)
as dependent variables controlling for prespecified confounders (age, sex, cups of coffee, beta blocker,
nocturnal heart rate) was used to assess the contribution of the arousal index, total sleep time with an
oxygen saturation <90% (TST90) and the AHI not due to arousals to HRV. The significance level was
set at P<0.01. Results: In 258 patients with OSA (mean ± SD age 62±10 years, BMI 29±4 kg/m2,
median (IQR) AHI 18.6/h (14.0–25.6), the arousal index (coef =0.42, P=0.002) was independently posi-
tively associated with SDNNIDX also after having controlled for potential confounders, whereas the AHI
(coef =0.22, P=0.030) and TST90 (coef =0.36, P=0.054) were not. The arousal index—but not TST
and AHI—was also independently associated with LF/HF. Conclusions: In OSA, pronounced sleep frag-
mentation is associated with higher nocturnal HRV and a sympatho-vagal imbalance with sympathetic
dominance. OSA severity and nocturnal hypoxaemia did not independently predict nocturnal HRV.
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Background: Obstructive sleep apnoea (OSA) results in sympathetic overdrive. Increased nocturnal heart 
rate variability (HRV) is a surrogate marker of autonomic disturbance. The aim was to study the association 
of the apnoea-hypopnea index (AHI), nocturnal hypoxaemia, and sleep fragmentation with nocturnal HRV 
to address the pathophysiological mechanisms underlying autonomic disturbance in OSA.
Methods: Participants of the Sleep Hearth Health Study with available data on nocturnal HRV and an AHI 
≥10/h have been included in this cross-sectional analysis. The main outcome of interest was the association 
of sleep fragmentation, nocturnal hypoxaemia, and the AHI with nocturnal HRV. Multivariate regression 
modelling with the mean of the standard deviations of normal-sinus-to-normal-sinus-interbeat intervals 
in all 5-minute segments (SDNNIDX) and with low to high frequency power-ratio (LF/HF) as dependent 
variables controlling for prespecified confounders (age, sex, cups of coffee, beta blocker, nocturnal heart rate) 
was used to assess the contribution of the arousal index, total sleep time with an oxygen saturation <90% 
(TST90) and the AHI not due to arousals to HRV. The significance level was set at P<0.01.
Results: In 258 patients with OSA (mean ± SD age 62±10 years, BMI 29±4 kg/m2, median (IQR) 
AHI 18.6/h (14.0–25.6), the arousal index (coef =0.42, P=0.002) was independently positively associated 
with SDNNIDX also after having controlled for potential confounders, whereas the AHI (coef =0.22, 
P=0.030) and TST90 (coef =0.36, P=0.054) were not. The arousal index—but not TST and AHI—was also 
independently associated with LF/HF.
Conclusions: In OSA, pronounced sleep fragmentation is associated with higher nocturnal HRV and a 
sympatho-vagal imbalance with sympathetic dominance. OSA severity and nocturnal hypoxaemia did not 
independently predict nocturnal HRV.
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Introduction
Obstructive sleep apnoea (OSA) defined by an elevated 
apnoea-hypopnoea-index (AHI) is highly prevalent 
in the adult population (1,2). However, only a part of 
this OSA population has a clinically relevant OSA that 
indicates treatment based on symptoms, sleep quality, 
or cardiovascular comorbidities. There are different 
phenotypes with different symptom burden and different 
cardiovascular effects of OSA (3-5). There is a poor 
correlation between OSA severity based on the AHI and 
symptoms. However, in epidemiological studies, OSA 
severity was an independent predictor of cardiovascular 
consequences with a higher likelihood of hypertension and 
cardiovascular events in severe OSA in longitudinal studies 
(6-9). OSA is characterised by recurrent episodes of partial 
or complete upper airway obstruction during sleep, leading 
to nocturnal intermittent hypoxia, arousals, intrathoracic 
pressure oscillations, and hypercapnia, resulting in increased 
sympathetic activity and disturbed autonomic balance. 
Nocturnal intermittent hypoxia has been suggested as 
the most relevant underlying mechanism of sympathetic 
overdrive and elevated blood pressure in OSA models 
(10,11). However, the role of sleep fragmentation in 
increasing sympathetic activity has been discussed as well 
(12-14).
The role of the AHI and the oxygen desaturation 
index (ODI) as conventional OSA severity markers in 
explaining cardiovascular effects of OSA is currently under 
discussion, probably due to their neglect of some crucial 
pathophysiologic factors that do not allow them to be used 
as marker of autonomic imbalance (15,16). Autonomic 
disturbance induced by OSA might be an additional factor 
of prognostic relevance in OSA.
In order to assess the pathophysiologic interplay 
between OSA and sympathetic override, the autonomic 
nervous system has been investigated directly by means of 
microneurography as well as indirectly through baroreflex 
sensitivity, cold pressor test, handgrip test, measurement of 
urinary catecholamine excretion, and heart rate variability 
(HRV) analysis during sleep or wake (14). Nocturnal HRV is 
a surrogate marker of autonomic regulation and sympatho-
vagal balance during sleep, and HRV has been shown to 
be altered in OSA. The prognostic role of nocturnal HRV 
regarding cardiovascular outcomes is currently under 
investigation (17). Moreover, it is acknowledged that stress 
is correlated with an increase in HRV during non-rapid 
eye movement (NREM) sleep, which represents the main 
part of sleep (13,18). Among patients with OSA, a raise in 
HRV during sleep is probably related to the adrenergic 
bursts caused by intermittent hypoxia and arousals as well 
as intrathoracic pressure swings (14,19). In addition, a 
decreased baroreflex control has been shown in OSA (20,21), 
potentially also in association with hypertension. However, 
whether nocturnal intermittent hypoxia is independently 
associated with changes in HRV or whether it acts on 
sympathetic activation by triggering arousals is less clear.
In this cross-sectional analysis, sleep fragmentation 
and nocturnal hypoxia have been studied as potential 
HRV modulators in a real-life population of subjects with 
OSA in order to assess the role of the pathophysiological 
mechanisms involved in OSA on autonomic imbalance.
The main hypothesis of this study was that in OSA, both 
markers of sleep fragmentation and nocturnal hypoxaemia 
are associated with an increase in nocturnal HRV (Figure 1). 
We present the following article in accordance with the 




The Sleep Heart Health Study (22) enrolled men 
and women aged 40 years and older to undergo a 
polysomnography (PSG) between 1995 and 1998. The data 
of the polysomnographic recording of these participants 
has been used to conduct HRV analysis (n=486). These 
data were available for download from the website of the 
National Sleep Research Resource (https://sleepdata.org). 
The download and usage of the data has been authorised 
by The Brigham and Women’s Hospital through its 
Division of Sleep and Circadian Disorders (Boston, MA, 
USA) after the submission and acceptance of a Data Access 
and Use Agreement containing the details of this cross-
sectional analysis. The National Sleep Research Resource 
offers free access to large collections of de-identified 
physiological signals and clinical data elements collected in 
well-characterised research cohorts and clinical trials and is 
supported by Grant Number HL114473 from the National 
Heart, Lung, and Blood Institute, National Institutes of 
Health (USA). The study was conducted in accordance with 
the Declaration of Helsinki and the Harmonized Tripartite 
Guideline for Good Clinical Practice from the International 
Conference on Harmonization. This study was reviewed 
and approved by the institutional review boards of each site 
S131Journal of Thoracic Disease, Vol 12, Suppl 2 October 2020
© Journal of Thoracic Disease. All rights reserved. J Thorac Dis 2020;12(Suppl 2):S129-S138 | http://dx.doi.org/10.21037/jtd-cus-2020-005
of the SHHS centres. All patients enrolled in the SHHS 
completed the informed consent form.
Eligibility criteria
Participants from the initial cohort have been excluded if 
they either presented with or reported atrial fibrillation or 
a higher degree atrioventricular block at the time of PSG, 
since these arrhythmias affect HRV analysis. Furthermore, 
only participants with a total sleep time of at least 
240 minutes and OSA defined by an AHI ≥10 episodes 
per hour of sleep have been included. The threshold of 
10 events per hour has been chosen in order to exclude 
borderline AHI values that might not reflect OSA (23-28). 
AHI was defined as the number of all apnoeas and 
hypopnoeas associated with an oxygen desaturation of 
at least 3% or an arousal per hour of sleep (29). For the 
definitions of the measurement methods please refer to 
the original paper (22) or the study protocol available on 
the website of the National Sleep Research Resource. 
According to the eligibility criteria, data of 258 participants 
were available for the analysis (Figure 2).
Extracted data
The following data were extracted for this analysis: age, 
sex, ethnicity, BMI, neck circumference, presence of 
atrial fibrillation, hypertension, heart failure, types of 
antihypertensive drugs, diabetes mellitus, smoking, pack 
years, cups of coffee within four hours before the sleep 
study, apnoea-hypopnea-index (3% & 4% dips) with and 
without arousals, % time with SpO2 <90%, mean nocturnal 
SpO2, sleep stages, time in bed, sleep efficiency, arousal 
index, blood pressure, heart rate, measures of HRV (normal 
sinus-to-normal sinus interbeat intervals in all 5-minute 
segments, ratio of low to high frequency power).
Outcomes
The main outcome of interest was the association of 
different pathophysiological features of OSA derived from 
PSG parameters—the arousal index, the percentage of 
the total sleep time with an oxygen saturation below 90% 
(TST90), and the AHI based on apnoeas and hypopnoeas 
associated with 3%-oxygen desaturations and not on 
arousals—with nocturnal HRV assessed in the time domain 
by normal sinus-to-normal sinus interbeat (NN) intervals 
in all 5-minute segments (SDNNIDX). This reflects mainly 
short-term HRV influenced by the autonomic nervous 
system.
A secondary outcome of interest was the association of 
these three PSG-derived parameters with nocturnal HRV in 
the time-frequency domain, quantified with the ratio of low 
to high frequency power (LF/HF) as marker of sympathetic 
to parasympathetic balance. The low and high frequency 
power reflect the NN interval spectral power between 0.04 
and 0.15 Hz and between 0.15 and 0.4 Hz, respectively. 
The HF is suggested to represent vagal modulation and is 
more affected by breathing (30).
Statistical analysis
In order to test the main hypothesis, we conducted a 
multiple regression analysis using SDNNIDX as dependent 
variable, expressed in ms. The HRV analysis of consecutive 
5 minute-segments, whose results were downloaded from 
Figure 1 Interplay between sleep fragmentation, intermittent 
nocturnal desaturation, and sympathetic override in OSA. The 
dotted lines represent the investigated relationship between OSA, 
arousals, intermittent nocturnal desaturations, and sympathetic 
activation. OSA, obstructive sleep apnoea.
Figure 2 Patient flow. AHI, apnoea-hypopnea index; HRV, heart 
rate variability.
Obstructive sleep apnoea
Sleep fragmentation Nocturnal hypoxaemia
Sympathetic overdrive
Patients whose PSG has been used 
for 5-minute segments-HRV analysis 
(n=486)
Patients included in the final analysis 
(n=258)
Atrial fibrillation 
Third-degree atrioventricular block 
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the website of the National Sleep Research Resource 
(https://sleepdata.org), has been conducted restricting the 
analysis to interbeat (NN) intervals below 2.5 seconds, and 
to only 5 minute-windows with at least 150 normal sinus 
beats. There was no overlap between the analysed 5-minute 
segments. To address the role of different aspects of OSA 
in nocturnal HRV, three different models with SDNNIDX 
(HRV) as dependent variable were created including 
either the arousal index as marker of sleep fragmentation, 
the TST90 as marker of nocturnal hypoxaemia, or the 
AHI not due to arousals (comparable to ODI as marker 
of intermittent hypoxia and conventional OSA severity) 
as independent variables, each model controlling for 
age, sex, use of beta-blockers, number of cups of coffee 
within 4 hours before bedtime, and heart rate. Since the 
ODI was not available in the dataset, the AHI based on 
3%-desaturations only and not on arousals was used as 
estimate of intermittent nocturnal hypoxaemia. The same 
regression analyses were performed using LF/HF ratio as 
dependent variables.
Residual analysis of the models has been performed to 
check the regression assumption. The inclusion of the pre-
specified controlling variables has been motivated according 
to current literature and physiology evidence. 
Descriptive statistics were reported across the patient 
sample, with means and standard deviation (SD) for 
continuous variables as well as numbers and percentages for 
categorical variables.
Considering an overall α significance level of 0.05 and 
four regression models, a two-sided P value below 0.01 
has been considered statistically significant according to a 
Bonferroni correction.
Statistical analyses have been performed with Stata/SE 
15.1 (TX, USA).
Other relevant information
The study has been conducted according to the Strengthening 
the reporting of observational studies in epidemiology 
(STROBE) Statement for cross-sectional studies (31).
Results
The cohort consisted of 258 middle-aged (mean ± SD 
age of 62.3±9.8 years) men (59%) and women (41%) with 
overweight (mean ± SD BMI of 28.5±4.2 kg/m2) with mostly 
mild to moderate obstructive sleep apnea (AHI >30/h 
in 18%) without relevant hypoxic burden.
The baseline characteristics of the cohort are reported in 
Table 1.
The regression models studying the association of the 
arousal index as marker of sleep fragmentation, TST90 as 
marker of nocturnal hypoxaemia, and the AHI not based 
on arousals as marker of OSA severity and as surrogate 
marker of intermittent hypoxaemia (since ODI was not 
available) with nocturnal HRV (SDNNIDX) used age, sex, 
beta blocker therapy, cups of coffee within 4 hours before 
bedtime, and mean nocturnal heart rate as prespecified 
covariates. A statistically significant positive association 
between the arousal index and nocturnal HRV as dependent 
variable (SDNNIDX) was found also after having controlled 
Table 1 Baseline characteristics of the analysed cohort 
Variable Data of the cohort
N 258
Age, y 62.3±9.8




Beta-blocker therapy, n (%) 12 [5]
Cups of coffee before bedtime, n 0.06±0.42
Systolic office blood pressure, mmHg 124.6±17.2
Diastolic office blood pressure, mmHg 73.8±10.0
Arousal Index, n/h - median (IQR) 19.0 (13.9–25.5)
TST90, % - median (IQR) 0.5 (0.04–2.0)
Total Sleep Time, min 375±50
AHIa, n/h - median (IQR) 18.6 (14.0–25.6)
AHI, n/h - median (IQR) 14.9 (9.6–21.3)
AHIa 10–14.9/h, n (%) 82 (31.8)
AHIa 15–29.9/h, n (%) 130 (50.4)
AHIa >30/h, n (%) 46 (17.8)
SDNNIDX, ms - median (IQR) 52.0 (40.8–65.6)
LF/HR - median (IQR) 2.2 (1.3–3.4)
If not otherwise specified, data are shown as mean ± SD. AHI, 
apnoea-hypopnea index with hypopnoeas based on 3%-oxygen  
desaturations only; AHIa, apnoea-hypopnoea index with  
hypopnoeas based on both 3%-oxygen desaturations and 
arousals. IQR, interquartile range; SD, standard deviation; 
TST90, total sleep time with peripheral oxygen saturation below 
90%; SDNNIDX, mean of the standard deviations of normal  
sinus-to-normal sinus interbeat (NN) intervals in all 5-minute 
segments; LF/HF, low to high frequency power.
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for the above listed confounding factors with a coefficient 
of 0.42 (95% CI, 0.16–0.68), P=0.002 (Table 2). Using a 
level of significance of P<0.01, there was no evidence for a 
statistically significant association between TST90 [coef. 
0.40 (95% CI, 0.04–0.76), P=0.03; see Table 3] nor between 
the AHI not due to arousals [coef. 0.22 (95% CI, 0.02–0.41), 
P=0.03; see Table 4] and nocturnal HRV (SDNNIDX) after 
controlling for confounders.
In a regression model including all three parameters of 
interest—the arousal index, TST90, and the AHI not due 
to arousals—controlling for age, sex, use of beta blockers, 
cups of coffee within four hours before bedtime, and heart 
rate, the arousal index was the only variable independently 
associated with nocturnal HRV (SDNNIDX) among the 
analysed dependent variables [coef. 0.37 (95% CI, 0.08–
0.65), P=0.01; see Table 5].
The regression models using the LF/HF ratio as 
dependent variable and controlling for the same covariates 
as above, demonstrated a statistically significant independent 
association between the arousal index and the LF/HF ratio 
[coef. 0.03 (95% CI, 0.01–0.06), P=0.004]. There was no 
evidence for an independent association between TST90 
[coef. −0.03 (95% CI, −0.06–0.00), P=0.09] and the LF/HF 
ratio nor between the AHI not due to arousals and the LF/
HF ratio [coef. −0.01 (95% CI, −0.03–0.01), P=0.34].
Discussion
In this cross-sectional analysis of a subpopulation of the 
Sleep Heart Health Study with OSA, the impact of sleep 
fragmentation, nocturnal hypoxaemia, and OSA severity on 
short-term nocturnal HRV has been studied. The arousal 
index was independently associated with an increased 
HRV in both the time domain (SDNNIDX) and the time-
frequency domain (LF/HF ratio) as the best predictor 
of HRV out of different sleep-study derived parameters 
Table 2 Multiple linear regression analysis between SDNNIDX and the arousal index
SDNNIDX, ms Regression coefficient Confidence interval P value
Arousal Index, n/h 0.42 0.16 to 0.68 0.002
Age, y −0.28 −0.53 to −0.02 0.036
Female sex −5.06 −10.06 to −0.07 0.047
Beta-blocker therapy −7.78 −18.82 to 3.25 0.166
Cups of coffee before bedtime, n 6.22 0.41 to 12.04 0.036
Heart rate, bpm −1.21 −1.51 to −0.91 <0.001
Adjusted R
2
=0.29. SDNNIDX, mean of the standard deviations of normal sinus-to-normal sinus interbeat (NN) intervals in all 5-minute  
segments.
Table 3 Multiple linear regression analysis between SDNNIDX and TST90
SDNNIDX, ms Regression coefficient Confidence Interval P value
TST90, % 0.40 0.04 to 0.76 0.029
Age, y −0.32 −0.58 to −0.06 0.017
Female sex −4.81 −9.85 to 0.24 0.062
Beta-blocker therapy −9.18 −20.28 to 1.92 0.105
Cups of coffee before bedtime, n 5.36 −0.46 to 11.17 0.071
Heart rate, n/min −1.27 −1.57 to −0.96 <0.001
Total sleep time, h −0.04 −0.09 to 0.01 0.080
Adjusted R
2
=0.27. SDNNIDX, mean of the standard deviations of normal sinus-to-normal sinus interbeat (NN) intervals in all 5-minute 
segments; TST90, total sleep time with peripheral oxygen saturation below 90%. In this model, total sleep time has been added as a  
controlling variable since TST90 is not a frequency index.
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representing sleep fragmentation, nocturnal hypoxaemia, 
and OSA severity. This suggests that sleep fragmentation is 
associated with autonomic cardiac imbalance during sleep 
in patients with OSA. An increase of 1 arousal per hour 
during the night was associated with a proportional increase 
of 0.42 ms of SDNNIDX, an estimate of HRV. Considering 
a median of 19 arousals per hour in the analysed cohort, a 
median increase of 8 ms of SDNNIDX can be estimated 
over the night according to the regression model, which 
represents an increase of 15% in nocturnal SDNNIDX 
(median 52 ms). Measures of nocturnal hypoxaemia and 
OSA severity (TST90 and AHI not based on arousals, 
respectively) were not independently associated with 
nocturnal HRV in this cohort including patients with mild, 
moderate, and severe OSA that, however, consisted overall 
mainly of mild and moderate OSA (>80%). Considering 
that a dose-response relationship between AHI and HRV 
has been observed (14,32), our findings suggest that this 
might mainly be explained by respiratory events associated 
with arousals (33). 
Nocturnal short-term HRV has been used as surrogate 
marker for autonomic cardiac regulation and sympatho-
vagal balance during sleep (17,34,35). The autonomic 
nervous system modulates cardiac function during sleep. 
Physiologically, there is a gradually increasing vagal 
dominance during NREM sleep stages 1-3 but a higher 
sympathetic activity during REM sleep (36,37). In OSA, 
there is a shift of the sympatho-vagal balance towards 
sympathetic predominance (38). However, HRV during 
sleep in OSA cannot be solely attributed to autonomic 
neural regulation. Blood pressure surges during obstructive 
respiratory events influence heart rate via the baroreflex and 
respiration via parasympathetic-mediated respiratory sinus 
arrest. Moreover, enhanced chemoreflexes and non-neural 
Table 4 Multiple linear regression analysis between SDNNIDX and the AHI not due to arousals
SDNNIDX, ms Regression coefficient Confidence interval P value
AHI, n/h 0.22 0.02 to 0.41 0.030
Age, y −0.27 −0.52 to −0.11 0.041
Female sex −4.84 −9.93 to 0.25 0.062
Beta-blocker therapy −9.76 −20.91 to 1.40 0.086
Cups of coffee before bedtime, n 5.32 −0.52 to 11.16 0.074
Heart rate, n/min −1.20 −1.50 to 0.90 <0.001
Adjusted R
2
=0.27. AHI, apnoea-hypopnoea index with hypopnoeas based on 3%-oxygen desaturations only (not on arousals). SDNNIDX, 
mean of the standard deviations of normal sinus-to-normal sinus interbeat (NN) intervals in all 5-minute segments.
Table 5 Multiple linear regression analysis between SDNNIDX and arousal index, TST90, and AHI not due to arousals 
SDNNIDX, ms Regression coefficient Confidence interval P value
Arousal index, n/h 0.37 0.08 to 0.65 0.011
TST90, % 0.30 −0.10 to 0.70 0.141
AHI, n/h 0.03 −0.20 to 0.27 0.768
Age, y −0.31 −0.57 to −0.05 0.018
Female sex −4.68 −9.74 to 0.37 0.069
Beta-blocker therapy −8.66 −19.75 to 2.43 0.125
Cups of coffee before bedtime, n 5.99 0.18 to 11.80 0.043
Heart rate, n/min −1.25 −1.55 to −0.95 <0.001
Adjusted R
2
=0.30. SDNNIDX, mean of the standard deviations of normal sinus-to-normal sinus interbeat (NN) intervals in all 5-minute  
segments; TST90, total sleep time with peripheral oxygen saturation below 90%; AHI, apnoea-hypopnoea index with hypopnoeas based 
on 3%-oxygen desaturations only (not on arousals).
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factors like intrathoracic pressure oscillations play a role as 
well (37). Overall, the pattern of HRV is altered in OSA, 
but different changes have been described. 
When interpreting HRV, attention should be paid to the 
differences between 24-hour HRV and short-term HRV 
during sleep based on 5-minutes-intervals—they are not 
interchangeable. Autonomic cardiac control is regulated 
differently during wake and during different sleep stages. A 
decreased long-term HRV (24 h) and an increased LF/HF 
ratio are seen in hypertension and the latter has been described 
in OSA as well (39,40). A decreased HRV over 24 hours 
has been suggested as negative prognostic marker in 
cardiovascular disease (41). However, nocturnal short-term 
HRV based on SDNN reflects another component of HRV 
and—across all sleep stages—has been described in most 
but not all studies as longer in OSA compared to patients 
not having OSA (42-45).
In our study, the association between sleep fragmentation 
and SDNNIDX and LF/HF ratio were positive, suggesting 
an increased overall nocturnal HRV and a change in 
nocturnal autonomic function towards sympathetic activity. 
However, SDNNIDX was relatively low with 52 ms. Based 
on data from 24-hour-HRV analysis, it was suggested that 
an SDNN <50 ms is to be considered unhealthy, while an 
SDNN >100 ms reflects healthy (41). However, population 
means for SDNN and LF/HF ratio have been described as 
50±16 and 2.8±2.6 ms, respectively (46).
The finding that only arousal-based measures of OSA 
severity were independently associated with HRV but 
not measures of nocturnal hypoxaemia or intermittent 
hypoxaemia was not in line with the hypothesis of an 
independent association between intermittent hypoxaemia 
and HRV. Whether this finding is only applicable to this 
cohort of patients with mild to moderate OSA with a minor 
hypoxic burden or also to cohorts with more pronounced 
nocturnal hypoxaemia needs to be further studied. 
However, other data support that HRV is closer related 
to autonomic arousals than to intermittent hypoxaemia. 
Supplemental oxygen resulted in a significant reduction of 
a rise in morning blood pressure compared to sham using 
a CPAP therapy withdrawal model in OSA. However, 
attenuation of intermittent hypoxaemia resulted only in 
a neglectable (although statistically significant) reduction 
of the pulse rise index—a pulse oximetry-derived measure 
of HRV that is used as surrogate marker of autonomic 
arousals (47). The findings of this randomised controlled 
cross-over trial support that autonomic control of the 
cardiovascular system is affected by several different 
pathophysiological consequences and also supports 
that HRV might be closer related to arousal-mediated 
autonomic disturbance than to intermittent hypoxaemia-
mediated sympathetic overdrive (47).
This study has several limitations. The main limitation 
of this cross-sectional analysis is that the study population 
(derived from a general population sample with an AHI 
≥10/h, not a sleep clinic population) consists mainly of 
patients with mild-to-moderate OSA. An OSA population 
with more cases with severe OSA and a relevant hypoxic 
burden would be more suitable to study the association 
between the pathophysiological constraints of OSA and 
nocturnal HRV. Another limitation is that ODI was not 
available and that the AHI including only hypopnoeas based 
on 3%-desaturations and not on arousals had to be used 
as surrogate. In addition, intrathoracic pressure changes, 
which presumably affect HRV, were not assessed—however, 
oesophageal pressure is not a standard clinical assessment 
in OSA. HRV data were only available in a subset of the 
study population of the Sleep Heart Health Study, thus 
limiting the sample size for this analysis to a few hundreds. 
These limitations affect generalisability to a typical OSA 
population. Moreover, the statistical analysis revealed some 
degree of heteroscedasticity in the regression models. 
We summarise that based on our findings, sleep 
fragmentation seems to have a relevant pathophysiological 
effect on HRV among patients with OSA. Moreover, 
nocturnal hypoxaemia per se appears not to account for 
an increased HRV in this OSA population with, however, 
only a limited hypoxic burden. Nevertheless, intermittent 
hypoxaemia might affect HRV by triggering arousals. In 
line with our findings, arousal index was demonstrated to be 
stronger associated with sympathetic overactivity than the 
AHI in other cohort studies involving patients with OSA (48). 
Considering the interplay between OSA and autonomic 
cardiac dysfunction, the integration of HRV analysis in the 
diagnostic work-up of OSA might help to understand the 
role of sleep disordered breathing in autonomic dysregulation 
and support treatment recommendations for OSA. It has 
been shown that treatment of OSA by CPAP or hypoglossal 
nerve stimulation reduces the elevated HRV during sleep and 
that effective treatment of OSA reduces sympathetic override 
(49,50). The impact of this reduction on vascular outcomes 
in OSA remains to be further analysed.
Conclusions
Among patients with OSA, sleep fragmentation is associated 
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with an increased HRV and a shift of the sympatho-vagal 
balance to sympathetic dominance. This is important since 
it is well known that sympathetic overactivity results in 
increases in nocturnal and daytime blood pressure, one of 
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